CD30-positive cutaneous T-cell lymphoma and response to Brentuximab vedotin: 2 illustrative cases

Kabir Mody, Jill S. Wallace, Diane M. Stearns, George Bowers, Shannon R. Lacy, Norman B. Levy, Kathryn A. Zug, Frederick Lansigan

Research output: Contribution to journalArticle

11 Scopus citations
Original languageEnglish (US)
Pages (from-to)319-323
Number of pages5
JournalClinical Lymphoma, Myeloma and Leukemia
Volume13
Issue number3
DOIs
StatePublished - Jun 1 2013

Keywords

  • Cutaneous T-cell lymphoma
  • Cutaneous anaplastic large cell lymphoma
  • Mycosis fungoides

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Mody, K., Wallace, J. S., Stearns, D. M., Bowers, G., Lacy, S. R., Levy, N. B., Zug, K. A., & Lansigan, F. (2013). CD30-positive cutaneous T-cell lymphoma and response to Brentuximab vedotin: 2 illustrative cases. Clinical Lymphoma, Myeloma and Leukemia, 13(3), 319-323. https://doi.org/10.1016/j.clml.2012.12.008